SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/21.06.24

SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/21.06.24 Share Price

DE000SU7GDD3

Market Closed - Boerse Frankfurt Warrants 05:50:16 14/06/2024 pm IST
0.001 ^EUR	-95.65%

Current month	-96.43%
3 months	-99.63%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart VERTEX PHARMACEUTICALS INCORPORATED

Chart SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/21.06.24

Latest news about VERTEX PHARMACEUTICALS INCORPORATED

Vertex Pharmaceuticals Says Gene-Editing Therapy Demonstrates Clinical Benefits in Genetic Disease Trials	14/06	MT
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress	14/06	BU
Vertex Pharmaceuticals Insider Sold Shares Worth $1,089,840, According to a Recent SEC Filing	14/06	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $3,483,664, According to a Recent SEC Filing	14/06	MT

More news

Quotes 5-day view

Date	Price	Change
14/24/14	0.001	-95.65%
13/24/13	0.023	+2,200.00%
12/24/12	0.001	-98.28%
11/24/11	0.058	-15.94%
10/24/10	0.069	-50.71%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 05:50 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	VERTEX PHARMACEUTICALS INCORPORATED
Issuer	Société Générale
WKN	SU7GDD
ISIN	DE000SU7GDD3
Date issued	25/01/2024
Strike	540 $
Maturity	21/06/2024 (6 Days)
Parity	10 : 1
Emission price	0.7 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.78 €
Lowest since issue	0.001 €

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).

Sector

More about the company